Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
The Journal of Thoracic and Cardiovascular Surgery
|
March 1, 1985
Particle-induced coronary vasoconstriction during cardioplegic infusion. Characterization and possible mechanisms
D J Hearse, C Erol, L A Robinson, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1991
Selective 5-lipoxygenase inhibitor BW A4C does not influence progression of tissue injury in a canine model of regional myocardial ischaemia and reperfusion
M P Maxwell, C Marston, M R Hadley, et al.
The Thoracic and Cardiovascular Surgeon
|
October 1, 1986
Particle-induced coronary vasoconstriction in the rat heart: pharmacological investigation of underlying mechanisms
D J Hearse, B Sonmez, C Saldanha, et al.
The American Journal of Cardiology
|
May 1, 1983
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts
D M Yellon, D J Hearse, M P Maxwell, et al.
Journal of Molecular and Cellular Cardiology
|
October 1, 1986
Calcium antagonists and evolving myocardial infarction: studies of the effects of nifedipine on tissue ATP, collateral flow and infarct size in the closed chest dog
Y Kudoh, D J Hearse, M P Maxwell, et al.
The Canadian Journal of Cardiology
|
March 1, 1987
Spatial and temporal characteristics of the transmural distribution of collateral flow and energy metabolism during regional myocardial ischemia in the dog
M Fukunami, D M Yellon, Y Kudoh, et al.
Advances in Myocardiology
|
January 1, 1985
Infarct-size limitation--real or artifactual. Studies with flurbiprofen using a reperfusion model
D M Yellon, M P Maxwell, D J Hearse, et al.
Lancet (London, England)
|
March 4, 1972
An azobis-arylimidazo-pyridinium derivative: a rapidly acting non-depolarising muscle-relaxant. Clinical study
B R Simpson, L Strunin, T M Savege, et al.
Neurogastroenterology and Motility
|
June 3, 1999
The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat
N M Clayton, R Sargent, A Butler, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
The Journal of Thoracic and Cardiovascular Surgery
|
March 1, 1985
Particle-induced coronary vasoconstriction during cardioplegic infusion. Characterization and possible mechanisms
D J Hearse, C Erol, L A Robinson, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1991
Selective 5-lipoxygenase inhibitor BW A4C does not influence progression of tissue injury in a canine model of regional myocardial ischaemia and reperfusion
M P Maxwell, C Marston, M R Hadley, et al.
The Thoracic and Cardiovascular Surgeon
|
October 1, 1986
Particle-induced coronary vasoconstriction in the rat heart: pharmacological investigation of underlying mechanisms
D J Hearse, B Sonmez, C Saldanha, et al.
The American Journal of Cardiology
|
May 1, 1983
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts
D M Yellon, D J Hearse, M P Maxwell, et al.
Journal of Molecular and Cellular Cardiology
|
October 1, 1986
Calcium antagonists and evolving myocardial infarction: studies of the effects of nifedipine on tissue ATP, collateral flow and infarct size in the closed chest dog
Y Kudoh, D J Hearse, M P Maxwell, et al.
The Canadian Journal of Cardiology
|
March 1, 1987
Spatial and temporal characteristics of the transmural distribution of collateral flow and energy metabolism during regional myocardial ischemia in the dog
M Fukunami, D M Yellon, Y Kudoh, et al.
Advances in Myocardiology
|
January 1, 1985
Infarct-size limitation--real or artifactual. Studies with flurbiprofen using a reperfusion model
D M Yellon, M P Maxwell, D J Hearse, et al.
Lancet (London, England)
|
March 4, 1972
An azobis-arylimidazo-pyridinium derivative: a rapidly acting non-depolarising muscle-relaxant. Clinical study
B R Simpson, L Strunin, T M Savege, et al.
Neurogastroenterology and Motility
|
June 3, 1999
The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat
N M Clayton, R Sargent, A Butler, et al.
Page
of 2